Equinox is engaged in all aspects of medical cannabis, from Land-to-Brand – developing our own processes and IP, researching proprietary strains and formulating unique products.

Michael Abbott is the cofounder and Executive Chairman of The Cannabist Company (formerly Columbia Care), the largest pharmaceutical manufacturer of cannabis related medicines in the United States, with a market cap of over CAD$1.1 billion. Founded in 2012, Columbia Care operates 130 facilities including 99 dispensaries and 31 cultivation and manufacturing facilities, 300 acres of outdoor cultivation, with licences in 18 U.S. jurisdictions.

Michael started his financial career at Swiss Bank Corporation/SBC O’Connor and later worked at Goldman Sachs. He also launched and ran two hedge funds and managed a multi-billion-dollar fund-of-funds. Michael was also CIO of the endowment of Cornell University. Prior to his career in finance, Michael served on the London Police Force in the 1980s.

Xan is the Company’s Chief Executive Officer. Xan cofounded Equinox in 2018 having been active in the sector since 2015. Xan has pioneered leading initiatives in the cannabis sector and was a founder of policy group Cannabis Innovate. As well as being involved in initiatives to legalise medical cannabis in the UK and Morocco, he has played an integral role in the legalisation of medical cannabis in Saint Vincent and the Grenadines, which included an amnesty bill for local farmers. He also led the development of OXON, the Oxford medical cannabis brand and the Mr NICE cannabis brand, now stocked in Selfridges and distributed through partners across the UK and Europe.

Prior to cofounding Equinox, Xan spent 11 years as a founding member and director of the company Bluewater Bio, an international water and wastewater company providing technology, engineering, operation and infrastructure management services to the international market. Xan currently acts as an advisor to an array of medical and engineering firms.

Neil is a cofounder of Equinox and is also a Managing Partner at Kingsley Capital Partners LLP, a multifamily office based in London, where he is responsible for sourcing and managing investments across all sectors.

Neil has worked in finance since 2003, for both J Rothschild Capital Management (RIT Capital Partners PLC) and Morgan Stanley. Through Kingsley, Neil has founded several businesses, including Oxford Cannabinoid Technologies Holdings PLC. Neil holds a BA, MA in Biological Sciences from Oxford University and an MBA from Harvard Business School.

Lord Cholmondeley is the descendant of Sir Robert Walpole, the first Prime Minister of Great Britain. David runs agricultural estates in Norfolk and Cheshire, including one of the largest organic enterprises in the country.

David was appointed Knight Cross of the Victorian Order in 2010, and Deputy Lieutenant of Norfolk in 2016. David is a trustee of a number of UK charitable organisations.

Paul is the current Executive Chairman of luxury automotive, motorsport and technology company McLaren Group after working as a Chairman of Compass Group Plc and various senior roles in Private Equity. He was also previously the Chief Executive Officer of Diageo plc for 13 years. He is also a non-executive director of FedEx Corporation and McDonald’s Corporation.

Andrew trained as a solicitor with Herbert Smith’s in London before becoming a specialist in intellectual property law at Hammonds, where he worked for 25 years.

Most recently, Andrew served as Managing Partner of Andrew Clay Legal. Andrew holds a 1st Class Honours in Law from the University of St Andrews.